<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">481</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2026.7.2.178-185</article-id>
<title-group><article-title>Biochemical and Histopathological Investigation of Pseudomonas Aeruginosa Infection on The Spleen, Kidneys and Liver of Rabbit Oryctolagus Cuniculus</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Nwaye</surname><given-names>Malak Imad</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Sabaagh</surname><given-names>Shaimaa J AL</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<aff id="aff1"><label>1</label>AL-Furat Al-Awsat Technical University, Najaf, Iraq</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2026</year></pub-date>
<volume>7</volume>
<issue>2</issue>
<fpage>178</fpage>
<lpage>185</lpage>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/481/biochemical-and-histopathological-investigation-of-pseudomonas-aeruginosa-infection-on-the-spleen"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/481/download"/>
<abstract><p>For the purpose determine the association between biochemical indicators and severity of histopathological lesions, this study used 20 rabbits, 10 in each of the T1 control and T2 groups, to isolate, identify, and investigate the effects of Pseudomonas aeruginosa illness on the spleen, kidneys, and liver of rabbits. P. aeruginosa isolation and identification from an infected rabbit. A thin fibrous capsule, a red pulp, and white pulp were visible in the microscopic sections of the normal group&apos;s spleen, which normally lacks the organized nodules seen in mammals. In contrast, the infected group&apos;s splenic sinuses showed significant dilatation and congestion of the red pulp with a mild hemorrhagic concentration, Melano macrophage accumulation, bleeding, lymphocytosis, an and proliferation of white pulp follicles, which are indicators of oxidative damage and an active immune system response. Vacuolation, necrosis, and sloughing of the renal tubules&apos; epithelial cells were signs of severe cellular degeneration, and the primary lesion in the kidney was thrombus in the blood vessels accompanying inflammatory cells. In the normal group, the liver is enveloped by a thin capsule alongside simple squamous epithelium and is composed of polyhedral hepatocytes with sinusoids and a central vein, while in group T2 showed hepatocyte granular and degeneration, capillary endothelium activation, and Kupffer cells, Vascular edema, hemorrhage, degeneration, congested fibrosis, and inflammation of hepatocytes, a sinusoid contraction, and bile duct hyperplasia defined the histopathological changes. Spleen, liver, and kidney function measures were all altered in the experimental rabbits. Urea levels were markedly elevated, while rabbits inoculated with P. aeruginosa had elevated levels of the uric acid, creatinine levels, alanine aminotransferase, and aspartate aminotransferase. In conclusion, Pseudomonas aeruginosa-induced infections in experimental rabbits showed histopathologic lesions and abnormalities in the liver, kidneys, and spleen. Bacterial infections are one of the main issues that laboratory animals face. Due to the dangers and inefficiency of drugs, an effective treatment without negative side effects is needed for these common illnesses.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Rabbit</kwd><kwd>P aeruginosa</kwd><kwd>biochemical</kwd><kwd>spleen</kwd><kwd>kidneys and liver</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Saraf, S. K., &amp; Kumaraswamy, V. (2013). Basic research: Issues with animal experimentations. Indian Journal of Orthopaedics, 47(1), 6-9.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Petetta, F., &amp; Ciccocioppo, R. (2021). Public perception of laboratory animal testing: Historical, philosophical, and ethical view. Addiction biology, 26(6), e12991.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Bryda E. C. (2013). The Mighty Mouse: the impact of rodents on advances in biomedical research. Missouri medicine, 110(3), 207–211.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Neziri, S., Köseoğlu, A. E., G., Özgültekin, B., &amp; Özgentürk, N. Ö. (2024). Animal models in neuroscience with alternative approaches: Evolutionary, biomedical, and ethical perspectives. Animal models and experimental medicine, 7(6), 868–880.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Nguyen N.T., Gras E., Tran N.D., Doan T.N., Diep B.A. (2021). Pseudomonas aeruginosa ventilator-associated pneumonia rabbit model for preclinical drug development. Antimicrob. Agents Chemother. 2021;65:e02724-02720. doi: 10.1128/AAC.02724-20.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Zhivkova K, Stoev S, Petrov V, Ivanov V. (2025). Susceptibility to Secondary Bacterial Infections in Growing Rabbits Exposed to Ochratoxin A and Protected or Not by Herbal Supplements. Toxins.; 17(10):507. https://doi.org/10.3390/toxins17100507.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Gras E., Vu T., Vu Vi Tran G., Schneider-Smith E., Povoa N., Povoa H., Delaye T., Valour F., An Diep B. (2202). Validation of a Rabbit Model of Pseudomonas aeruginosa Acute Pneumonia. Open Forum Infect. Dis. 2019;6:S750–S751. doi: 10.1093/ofid/ofz360.1882.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Mitsdoerffer, M.; Lee, Y; Jäger, A.; Kim, H; Korn, T; Kolls, J.; Cantor, H.; Bettelli, E. and Kuchroo, V. (2010). Proinflammatory T helper type 17 cells are effective B-cell helpers. PNAS. 107(32):14292–14297.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Mahmoud, N. M. (2009). Comparative study of antigens effect prepared from Pseudomonas aeruginosa from human skin burn in immunized mice. MSc. Thesis. College of Veterinary Medicine / Zoonotic Disease-University of Baghdad-Iraq.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Takase, H.; Nitanai, H.; and Otani, T. (2000). Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice. Infect Immun,,(68):1834-9.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Drenkard, E. and Ausubel, F. M. (2002). Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature (416):740-743.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Dietert R.R.; Bunn T.L., and Lee J.E. (2010). The delayed type hypersensitivity assay using protein and xenogeneic cell antigens. Methods Mol Biol., (598):185-194.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Gocke, K.; Baumann, U.; Hagemann, H.; Gabelsberger, J.; Hahn, H.; Freihorst, J. and von Specht, B.U. (2003). Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule. FEMS Immunol. Med. Microbiol. (37):167– 171.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Hashemi, F.B., Behrouz, B., Korpi, F. and Fatemi, M.J., (2020). A trivalent vaccine consisting of “flagellin A+ B and pilin” protects against Pseudomonas aeruginosa infection in a murine burn model.Microbial pathogenesis,138, p.103697.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Huszczynski, S.M., Lam, J.S. and Khursigara, C.M., (2019). The role of P. aeruginosa lipopolysaccharide in bacterial pathogenesis and International Journal of Medical and All Body Health Research www.allmedicaljournal.com physiology. Pathogens, 9 (1): 6.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Wood, S.J., Kuzel, T.M. and Shafikhani, S.H., (2023). Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics.Cells,12(1), p.199.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Thomas, L. D.; Kyd, J. M.; Bastin, D. A.; Dunkley, M. L. and Cripps, A. W. (2003). Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. (37):155–160.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Suvarna SK, Layton C, Bancroft JD. (2018). Bancroft , s theory and practice of histological techniques, 8 th ed. Churchill Livingstone Elsevier Philadelphia.; 176 -725.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Thomas, L. D.; Dunkley, M. L.; Moore, R.; Reynolds, S.; Bastin, D. A.; Kyd, J. M. and Cripps, A. W. (2000). Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung. Vaccine (19):348–357.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Theilacker, C.; Coleman, F. T.; Mueschenborn, S.; Llosa, N.; Grout, M. and Pier, G. B. (2003). Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infect. Immun. (71):3875–3884.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Pier, G. B. (2003). Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen. Carbohydr. Res. (338):2549–2556.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Xu J., Rajagopolan C., Hou X., Chen E., Boucher R.C., Sun F. Rabbit models for cystic fibrosis. Pediatr. Pulmonol. 2016;51:158–159.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Guoqi W., Zhirui L., Song W., Tongtong L., Lihai Z., Licheng Z., Peifu T. Negative pressure wound therapy reduces the motility of Pseudomonas aeruginosa and enhances wound healing in a rabbit ear biofilm infection model. Antonie Leeuwenhoek. 2018;111:1557–1570. doi: 10.1007/s10482-018-1045-5.</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>Kuo C-F, Luo Y-H, J-J, Lei H-Y, et al. (2004). Histopathologic changes in kidney and liver correlate with streptococcal pyrogenic exotoxin B production in the mouse model of group A streptococcal infection. Microb Pathogen.;36:273-85.</mixed-citation></ref>
<ref id="R25"><label>25</label><mixed-citation>Razook, B. R., Al-ani, A. N. ., &amp; Mahmood, M. M. (2020). Hematological Picture of Rabbits Immunized with Pseudomonas aeruginosa. The Iraqi Journal of Veterinary Medicine , 44((E0), 64 -68. https://doi.org/10.30539/ijvm.v44i(E0).1023.</mixed-citation></ref>
<ref id="R26"><label>26</label><mixed-citation>Al-Awadi AQ. (2017). The influence of Pseudomonas aeruginosa outer membrane antigens on experimental bone infection in rabbits. Int J Sci Nat.; 8(2): 289-297.</mixed-citation></ref>
<ref id="R27"><label>27</label><mixed-citation>Pliska N.N. Pseudomonas aeruginosa as the main causative agent of osteomyelitis and its susceptibility to antibiotics. Drug Res. 2020;70:280–285. doi: 10.1055/a-1150-2372.</mixed-citation></ref>
<ref id="R28"><label>28</label><mixed-citation>Cerioli M., Batailler C., Becker C., Lustig S., Fessy M.-H., Laurent F. (2020). Pseudomonas aeruginosa implant-associated bone and joint infections: Experience in a regional reference center in France. Front. Med. 2020;7:513242. doi: 10.3389/fmed.2020.513242.</mixed-citation></ref>
<ref id="R29"><label>29</label><mixed-citation>Gürtler N., Osthoff M., Rueter F., Egli A., Bassetti S. (2019). Prosthetic valve endocarditis caused by Pseudomonas aeruginosa with variable antibacterial resistance profiles: A diagnostic challenge. BMC Infect. Dis.;19:530. doi: 10.1186/s12879-019-4164-3.</mixed-citation></ref>
<ref id="R30"><label>30</label><mixed-citation>Razvi S., Quittell L., Sewall A., Quinton H., Marshall B., Saiman L. (2009). Respiratory microbiology of patients with cystic fibrosis in the United States, Chest.;136:1554–1560.</mixed-citation></ref>
<ref id="R31"><label>31</label><mixed-citation>Speert D.P., Henry D., Vandamme P., Corey ME. (2002). Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg. Infect. Dis.;8:181.</mixed-citation></ref>
<ref id="R32"><label>32</label><mixed-citation>Salsgiver E.L., Fink A.K., Knapp E.A., LiPuma J., Saiman L. (2016). Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis. Chest. 149:390–400.</mixed-citation></ref>
<ref id="R33"><label>33</label><mixed-citation>Dowd S.E., Callaway T.R., Wolcott R.D., Sun Y., Edrington T.S. (2008). Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) BMC Microbiol.;8:125.</mixed-citation></ref>
<ref id="R34"><label>34</label><mixed-citation>Wei, C., Zhu, M., Petroll, W.M. and Robertson, D.M., (2014). Pseudomonas aeruginosa infectious keratitis in a high oxygen transmissible rigid contact lens rabbit model.Investigative ophthalmology &amp; visual science,55(9), pp.5890-5899.</mixed-citation></ref>
<ref id="R35"><label>35</label><mixed-citation>Schultz, M.J., Rijneveld, A.W., Florquin, S., Speelman, P.,. and Van D (2001). Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice.Journal of medical microbiology,50(9), pp.822-827.</mixed-citation></ref>
</ref-list></back>
</article>